V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20212522 | 20174659 | 1.57 | 59 | Curative (C) | 2020-09-29 | 2020-10-28 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 100163421 |
| 20212529 | 20174660 | 1.67 | 55.4 | null | 2022-01-30 | 2022-02-15 | Cetuximab 14 day | 02 | N | CETUXIMAB | 100018527 |
| 20212534 | 20174661 | 1.75 | 100.2 | Palliative (P) | null | 2018-12-08 | Trastuzumab | null | Y | TRASTUZUMAB | 100870178 |
| 20212538 | 20174662 | 1.59 | 65.85 | Palliative (P) | 2016-03-03 | 2017-10-24 | Capecitabine + Cisplatin | null | N | CAPECITABINE + CISPLATIN | 101013196 |
| 20212574 | 20174663 | 1.69 | 49.1 | Palliative (P) | null | 2022-03-08 | Cetuximab 14 day | 02 | N | TRASTUZUMAB | 101140772 |
| 20212580 | 20174664 | 1.7 | 50.4 | Palliative (P) | null | 2020-04-24 | Capecitabine + Cisplatin + RT | 02 | N | CAPECITABINE + CISPLATIN | 101602604 |
| 20212584 | 20174665 | 1.69 | 70.6 | Palliative (P) | 2022-03-30 | 2022-04-13 | Trastuzumab | 02 | N | TRASTUZUMAB | 101342937 |
| 20212597 | 20174666 | 1.76 | 85.6 | null | 2019-06-16 | 2019-06-16 | Capecitabine + Cisplatin | 02 | null | CAPECITABINE + CISPLATIN | 100685744 |
| 20212631 | 20174667 | 1.72 | 51.45 | Curative (C) | 2019-04-29 | 2020-03-14 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 101064080 |
| 20212633 | 20174668 | 1.43 | 75 | Palliative (P) | 2018-07-11 | 2018-07-15 | CETUXIMAB | 02 | N | CETUXIMAB | 101366201 |
| 20212640 | 20174669 | 1.71 | 64 | Curative (C) | null | 2017-08-10 | CETUXIMAB | 02 | N | CETUXIMAB | 101570229 |
| 20212644 | 20174670 | 1.85 | 77 | Palliative (P) | 2020-12-09 | 2020-12-30 | Capecitabine + Cisplatin | N | N | CAPECITABINE + CISPLATIN | 100189452 |
| 20212695 | 20174671 | 1.72 | 98.1 | Neo-adjuvant (N) | 2016-10-12 | 2016-10-26 | Capecitabine + Cisplatin + RT | 02 | N | CAPECITABINE + CISPLATIN | 101842993 |
| 20212703 | 20174672 | 1.66 | 88.95 | Neo-adjuvant (N) | 2020-05-26 | 2020-05-28 | CETUXIMAB | 02 | N | CETUXIMAB | 100117625 |
| 20212722 | 20174673 | 1.53 | 109 | Palliative (P) | null | 2021-04-07 | Cetuximab 14 day | 02 | N | CAPECITABINE + CISPLATIN | 100814811 |
| 20212728 | 20174674 | 1.56 | 99.2 | Palliative (P) | null | 2021-12-17 | CETUXIMAB | 02 | N | CETUXIMAB | 100299300 |
| 20212756 | 20174675 | 1.65 | 59.5 | Palliative (P) | 2021-12-30 | 2021-12-31 | Capecitabine + Cisplatin | null | N | CAPECITABINE + CISPLATIN | 100205602 |
| 20212761 | 20174676 | 1.75 | 72.7 | Curative (C) | 2021-01-20 | 2021-04-03 | CETUXIMAB | N | N | CETUXIMAB | 100079776 |
| 20212762 | 20174677 | 1.51 | 82.7 | Palliative (P) | 2022-01-16 | 2022-01-16 | Trastuzumab 21 day maintenance | 02 | N | TRASTUZUMAB | 100070157 |
| 20212775 | 20174678 | 1.52 | 67.8 | null | 2021-02-15 | 2021-03-10 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 101335856 |
| 20212783 | 20174679 | 1.64 | 49 | Palliative (P) | 2018-10-01 | 2018-10-01 | Capecitabine + Cisplatin + RT | 02 | N | CAPECITABINE + CISPLATIN | 100183131 |
| 20212808 | 20174680 | 1.66 | 63.1 | Palliative (P) | 2018-06-06 | 2018-08-11 | TRASTUZUMAB | 02 | Y | TRASTUZUMAB | 101017301 |
| 20212830 | 20174681 | 1.85 | 120 | Palliative (P) | 2021-02-25 | 2021-03-03 | CETUXIMAB | 02 | Y | CETUXIMAB | 100300272 |
| 20212839 | 20174682 | 1.75 | 50 | Palliative (P) | 2016-10-19 | 2016-10-30 | Cetuximab 14 day | 02 | N | CETUXIMAB | 100409557 |
| 20212842 | 20174683 | 1.59 | 102.9 | null | 2021-08-11 | 2021-08-19 | CETUXIMAB | 02 | null | CETUXIMAB | 100237198 |
| 20212862 | 20174684 | 1.73 | 71.1 | Palliative (P) | 2020-04-12 | 2020-04-26 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 101260720 |
| 20212887 | 20174686 | 1.78 | 69.7 | null | 2021-04-18 | 2021-04-24 | CETUXIMAB | 02 | null | CETUXIMAB | 101719179 |
| 20212902 | 20174687 | 1.7 | null | Palliative (P) | 2017-03-15 | 2017-04-19 | CETUXIMAB | 02 | N | TRASTUZUMAB | 100466821 |
| 20212923 | 20174688 | 1.76 | 64 | Palliative (P) | 2016-07-22 | 2016-08-18 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 100919768 |
| 20212936 | 20174689 | 1.72 | 57.9 | null | 2021-09-22 | 2021-10-10 | Cetuximab 14 day | 02 | null | CAPECITABINE + CISPLATIN | 101286163 |
| 20212938 | 20174690 | null | 75 | null | null | 2018-09-16 | CETUXIMAB | 02 | null | CETUXIMAB | 100282495 |
| 20212943 | 20174691 | 1.64 | 112 | Palliative (P) | 2020-11-14 | 2020-12-05 | Trastuzumab | 02 | N | TRASTUZUMAB | 100245207 |
| 20212960 | 20174692 | 1.72 | 75.35 | Palliative (P) | 2017-04-25 | 2017-09-18 | Cetuximab 14 day | 02 | Y | CETUXIMAB | 101647682 |
| 20212995 | 20174693 | 1.8 | 46.4 | null | 2020-07-16 | 2020-07-28 | Cetuximab 14 day | 02 | N | CETUXIMAB | 100296693 |
| 20213000 | 20174694 | 1.59 | 88 | Palliative (P) | 2017-03-27 | 2017-03-29 | CETUXIMAB | 02 | null | CETUXIMAB | 101800398 |
| 20213001 | 20174695 | 1.62 | 87.2 | null | 2020-10-24 | 2020-12-05 | CETUXIMAB | 02 | null | CETUXIMAB | 101608794 |
| 20213023 | 20174696 | 1.8 | 82.2 | null | 2022-01-04 | 2022-01-04 | Capecitabine + Cisplatin | 02 | null | CAPECITABINE + CISPLATIN | 101298531 |
| 20213039 | 20174697 | 1.61 | 56 | null | 2018-07-05 | 2018-07-20 | CETUXIMAB | 02 | null | TRASTUZUMAB | 101150775 |
| 20213045 | 20174698 | 1.62 | 50.4 | null | 2021-04-26 | 2021-04-26 | Trastuzumab 21 day maintenance | 02 | null | TRASTUZUMAB | 100417278 |
| 20213046 | 20174699 | 1.83 | 122 | Palliative (P) | 2020-12-20 | 2020-12-20 | CETUXIMAB | 02 | N | CAPECITABINE + CISPLATIN | 100763023 |
| 20213056 | 20174700 | 1.62 | 62 | Palliative (P) | null | 2022-03-13 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 100415647 |
| 20213073 | 20174701 | 1.72 | 70.25 | Palliative (P) | 2019-01-21 | 2019-01-25 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 100558066 |
| 20213074 | 20174702 | 1.82 | 87.6 | Palliative (P) | 2020-04-04 | 2020-04-12 | Cetuximab 14 day | 02 | N | CETUXIMAB | 100519227 |
| 20213092 | 20174703 | 1.7 | 49.1 | null | 2022-03-31 | 2022-04-09 | Trastuzumab | 02 | null | TRASTUZUMAB | 101647432 |
| 20213126 | 20174704 | 1.78 | 46.6 | Palliative (P) | 2021-02-05 | 2021-03-11 | Cetuximab 14 day | 02 | N | CETUXIMAB | 100450167 |
| 20213130 | 20174705 | 1.76 | 41.7 | Palliative (P) | 2019-10-04 | 2019-10-08 | Trastuzumab 21 day loading dose | 02 | N | TRASTUZUMAB | 101518676 |
| 20213156 | 20174706 | 1.71 | 75 | Palliative (P) | 2021-09-29 | 2022-04-14 | CETUXIMAB | 02 | N | CETUXIMAB | 100388992 |
| 20213158 | 20174707 | 1.76 | 82.4 | Palliative (P) | 2016-04-29 | 2016-06-18 | Cetuximab 14 day | 02 | N | CETUXIMAB | 101325699 |
| 20213160 | 20174708 | 1.72 | 89 | Palliative (P) | 2021-11-09 | 2021-12-02 | Cetuximab 14 day | 02 | N | CETUXIMAB | 100933067 |
| 20213168 | 20174709 | 1.76 | 82.4 | Palliative (P) | 2017-06-18 | 2017-12-02 | Trastuzumab 21 day loading dose | 02 | null | TRASTUZUMAB | 101783672 |